Danaparoid and blood bilirubin increased Patient Reports February 12, 2012

Danaparoid Side Effects Report #4967758-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 26, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #4975619-X
Danaparoid side effect was reported by a Health Professional from JAPAN on Mar 23, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: asthma , blood bilirubin increased, blood potassium increased, disseminated intravascular coagulation, emphysema, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died on 09/29/2003.

Danaparoid Side Effects Report #5027829-3
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #4873368-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2005. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIFAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.


Danaparoid Side Effects Report #4948454-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatine increased, blood potassium increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIPAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5097842-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 24, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatinine increased, pulmonary alveolar haemorrhage, renal impairment, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5033184-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5063640-5
Danaparoid side effect was reported by a Physician from JAPAN on July 06, 2006. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.

Danaparoid Side Effects Report #5020454-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Female patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased, protein total decreased, sepsis , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with SULPERAZON, FAMOTIDINE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, FLURBIPROFEN, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, ISEPAMICIN SULPHATE. Patient died.


Danaparoid Side Effects Report #4863934-X
Danaparoid side effect was reported by a Health Professional from JAPAN on Dec 13, 2005. Female patient, 37 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, septic shock, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, FAMOTIDINE, CARPERITIDE, DOBUTAMINE, PROPOFOL, FENTANYL CITRATE. Patient died.